Monosodium glutamate neonatal treatment induces cardiovascular autonomic function changes in rodents

Clinics

Volumn 67, Issue 10, 2012, Pages 1209-1214

  Konrad, Signorá Peres ^a   Farah, Vera ^b   Rodrigues, Bruno ^c,d   Wichi, Rogério Brandão ^e   Machado, Ubiratan Fabres ^c   Lopes, Heno Ferreira ^c,f   Schaan, Beatriz D'Agord ^a,g   de Angelis, Kátia ^f   Irigoyen, Maria Cláudia ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b MACKENZIE PRESBYTERIAN UNIVERSITY   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d SÃO JUDAS TADEU UNIVERSITY   (Brazil)

^e FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^f Nove de Julho University   (Brazil)

^g INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

Author keywords

Arterial Pressure; Autonomic Function; Insulin Resistance; Monosodium Glutamate; Obesity

Indexed keywords

FOOD ADDITIVE; GLUTAMATE SODIUM; INSULIN;

ANIMAL; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD; CARDIOVASCULAR FUNCTION; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; HEART; HEART RATE; HEMODYNAMICS; INSULIN RESISTANCE; MALE; NEWBORN; OBESITY; PATHOPHYSIOLOGY; RAT; TIME; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; ARTERIAL PRESSURE; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; DISEASE MODELS, ANIMAL; FOOD ADDITIVES; HEART; HEART RATE; HEMODYNAMICS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; RATS; RATS, WISTAR; SODIUM GLUTAMATE; TIME FACTORS;

EID: 84868329042     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(10)14     Document Type: Article

References (43)

1. Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197-209, http://dx.doi.org/10.1016/S0140-6736(05)67483-1.
2. Hall JE, Summers RL, Brands MW, Keen H, Alonso-Galicia M. Resistance to metabolic actions of insulin and its role in hypertension. Am J Hypertens. 1994;7(8):772-88.
3. Quilliot D, Fluckiger L, Zannad F, Drouin P, Ziegler O. Impaired autonomic control of heart rate and blood pressure in obesity: role of age and of insulin-resistance. Clin Auton Res. 2001;11(2):79-86, http:// dx.doi.org/10.1007/BF02322050.
4. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969;164(3880):719-21, http:// dx.doi.org/10.1126/science.164.3880.719.
5. Marmo MR, Dolnikoff MS, Kettelhut IC, Matsushita DM, Hell NS, Lima FB. Neonatal monosodium glutamate treatment increases epididymal adipose tissue sensitivity to insulin in three-month old rats. Braz J Med Biol Res. 1994;27(5):1249-53.
6. Valensi P, Doare L, Perret G, Germack R, Paries J, Mesangeau D. Cardiovascular vagosympathetic activity in rats with ventromedial hypothalamic obesity. Obes Res. 2003;11(1):54-64, http://dx.doi.org/10.1038/oby.2003.10.
7. Olney JW. Status of monosodium glutamate revisited. Am J Clin Nutr. 1973;26(7):683-85.
8. Lorden JF, Caudle A. Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse. Neurobehav Toxicol Teratol. 1986;8(5):509-19.
9. Oida K, Nakai T, Hayashi T, Miyabo S, Takeda R. Plasma lipoproteins of monosodium glutamate-induced obese rats. Int J Obes. 1984;8(5):385-91.
10. Clough RW, Aravich PF, Sladek CD. Monosodium glutamate neurotoxicity: a sex-specific impairment of blood pressure but not vasopressin in developing rats. Brain Res Bull. 1986;17(1):51-8, http://dx.doi.org/10.1016/0361-9230(86)90160-7.
11. Tokarev D, Kristova V, Kriska M, Jezova D. Treatment of neonatal rats with monosodium glutamate attenuates the cardiovascular reactivity to phenylephrine and angiotensin II. Physiol Res 1997;46(3):165-71.
12. Zamo FS, Lacchini S, Mostarda C, Chiavegatto S, Silva IC, Oliveira EM, et al. Hemodynamic, morphometric and autonomic patterns in hypertensive rats-Renin-Angiotensin system modulation. Clinics. 2010; 65(1):85-92, http://dx.doi.org/10.1590/S1807-59322010000100013.
13. Rodrigues B, Rosa KT, Medeiros A, Schaan BD, Brum PC, De Angelis K, et al. Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents. Cardiovasc Diabetol. 2011;10:26, http://dx.doi.org/10.1186/1475-2840-10-26.
14. Silva RJ, Bernardes N, Brito Jde O, Sanches IC, Irigoyen MC, De Angelis K. Simvastatin-induced cardiac autonomic control improvement in fructose-fed female rats. Clinics. 2011;66(10):1793-6.
15. Brito JO, Ponciano K, Figueroa D, Bernardes N, Sanches IC, Irigoyen MC, De Angelis K. Parasympathetic dysfunction is associated with insulin resistance in fructose-fed female rats. Braz J Med Biol Res. 2008;41(9):804-8, http://dx.doi.org/10.1590/S0100-879X2008005000030.
16. Triadou N, Portha B, Picon L, Rosselin G. Experimental chemical diabetes and pregnancy in the rat. Evolution of glucose tolerance and insulin response. Diabetes. 1982;31(1):75-9.
17. Von Diemen V, Trindade EN, Trindade MR. Experimental model to induce obesity in rats. Acta Cir Bras. 2006;21:425-9, http://dx.doi.org/10.1590/S0102-86502006000600013.
18. Bunyan J, Murrell EA, Shah PP. The induction of obesity in rodents by means of monosodium glutamate. Br J Nutr 1976;35(1):25-39.
19. Ribeiro Braga L, de Mello MA, Gobatto CA. Continuous and intermittent exercise: effects of training and detraining on body fat in obese rats. Arch Latinoam Nutr. 2004;54(1):58-65.
20. Mozes S, Sefcíkov Z, Lenhardt L, Racek L. Effect of adrenalectomy on the activity of small intestine enzymes in monosodium glutamate obese rats. Physiol Res. 2004;53(4):415-22.
21. Cunha NV, de Abreu SB, Panis C, Grassiolli S, Guarnier FA, Cecchini R, et al. Cox-2 inhibition attenuates cardiovascular and inflammatory aspects in monosodium glutamate-induced obese rats. Life Sci. 2010;87(11-12):375-81, http://dx.doi.org/10.1016/j.lfs.2010.07.014.
22. de Carvalho Papa P, Vargas AM, da Silva JL, Nunes MT, Machado UF. GLUT4 protein is differently modulated during development of obesity in monosodium glutamate-treated mice. Life Sci. 2002;71(16):1917-28, http://dx.doi.org/10.1016/S0024-3205(02)01948-3.
23. Defronzo RA. Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes. 1979;28(12):1095-101.
24. Thirone AC, Carvalheira JB, Hirata AE, Velloso LA, Saad MJ. Regulation of Cbl-associated protein/Cbl pathway in muscle and adipose tissues of two animal models of insulin resistance. Endocrinology. 2004;145(1):281-93.
25. de Souza CT, Nunes WM, Gobatto CA, de Mello MA. Insulin secretion in monosodium glutamate (MSG) obese rats submitted to aerobic exercise training. Physiol Chem Phys Med NMR. 2003;35(1):43-53.
26. Farah V, Elased KM, Chen Y, Key MP, Cunha TS, Irigoyen MC, et al. Nocturnal hypertension in mice consuming a high fructose diet. Auton Neurosci. 2006;130(1-2):41-50, http://dx.doi.org/10.1016/j.autneu.2006.05.006.
27. Martinez FJ, Rizza RA, Romero JC. High-fructose feeding elicits insulin resistance, hyperinsulinism, and hypertension in normal mongrel dogs. Hypertension. 1994;23(4):456-63, http://dx.doi.org/10.1161/01.HYP. 23.4.456.
28. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol 1991;260(4 Pt 2):R764-8.
29. Hall JE, Brands MW, Zappe DH, Dixon WN, Mizelle HL, Reinhart GA, et al. Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin-resistant dogs. Hypertension. 1995;25(5):994-1002, http:// dx.doi.org/10.1161/01.HYP.25.5.994.
30. Qadir E, Porter JP. Effect of insulin on regional vascular resistances in conscious rats. Am J Physiol. 1996;270(2 Pt 2):R450-5.
31. Richey JM, Poulin RA, Buchanan TA, Galperin E, Moore DM, Bergman RN. Failure of acute hyperinsulinemia to alter blood pressure is not due to baroreceptor feedback. Am J Hypertens. 1999;12(4 Pt 1):405-13, http:// dx.doi.org/10.1016/S0895-7061(98)00272-6.
32. Moreau P, Lamarche L, Laflamme AK, Calderone A, Yamaguchi N, de Champlain J. Chronic hyperinsulinaemia and hypertension: the role of the sympathetic nervous system. J Hypertens. 1995;13(3):333-40.
33. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1999;14;351(9101):478-84.
34. Su DF, Miao CY. Arterial baroreflex function in conscious rats. Acta Pharmacol Sin. 2002;23(8):673-9.
35. Grassi G, Dell'Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central peripheral obesity body fat distribution on sympathetic and baroreflex function in obese normotensive. J Hypertens. 2004;22(12):2363-9, http://dx.doi.org/10.1097/00004872-200412000-00019.
36. Krontorádová K, Honzíková N, Fiser B, Nováková Z, Závodná E, Hrstková H, et al. Overweight and decreased baroreflex sensitivity as independent risk factors for hypertension in children, adolescents, and young adults. Physiol Res. 2008;57(3):385-91.
37. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043-65, http://dx.doi.org/10.1161/01.CIR.93.5.1043.
38. Miller AW, Sims JJ, Canavan A, Hsu T, Ujhelyi MR. Impaired vagal reflex activity in insulin-resistant rats. J Cardiovasc Pharmacol. 1999;33(5):698-702, http://dx.doi.org/10.1097/00005344-199905000-00004.
39. Rehorek A, Kerecsen L, Müller F. Measurement of tissue catecholamines of obese rats by liquid chromatography and electrochemical detection. Biomed Biochim Acta. 1987;46(11):823-7.
40. Davy KP, Orr JS. Sympathetic nervous system behavior in human obesity. Neurosci Biobehav Rev. 2009;33(2):116-24, http://dx.doi.org/10.1016/j.neubiorev.2008.05.024.
41. Hellstrom HR. The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes-including reducing the risk of age and atherosclerosis. Med Hypotheses. 2007;68(2):415-433, http://dx.doi.org/10.1016/j.mehy.2006.05.031.
42. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405(6785):458-62.
43. Van Gaal LF, Mertens IL, De Block DE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875-80, http:// dx.doi.org/10.1038/nature05487.